A Role of CC Chemokines on the Pathogenesis of Herpes Simplex Encephalomyelitis
A Role of CC Chemokines on the Pathogenesis of Herpes Simplex Encephalomyelitis
批准号:
13670675
负责人:
NAKAJIMA Hideto
金额:
$1.6万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Th1/Th2 responses play an important role on the host defense against herpes simplex encephalomyelitis. Recently, some specific chemokines have been described as an initiator of Th1/Th2 responses. We investigated a role of monocyte chemoattractant protein (MCP)-1 in the pathogenesis of herpesvirus-induced encephalomyelitis (HSM). Anti-MCP-1 antibody greatly decreased HSM severity in mice infected with herpes simplex virus type 2 (HSM mice). HSM severity was markedly enhanced in mice previously treated with a mixture of interleukin (IL) 4 and -10. In response to stimulation with antigen, HSM mouse cells isolated from cerebrospinal fluids (CSF cells) produced IL-4 in culture fluids, however, IL-4 production decreased in CSF cells derived from HSM mice previously treated with anti-MCP-1 antibody. A macrophage population isolated in CSF cells from HSM mice (CSF-Mphi) produced MCP-1 in culture fluids. In response to stimulation with herpesvirus antigen, T cells isolated from CSF cells from HSM mice (CSF-T cells) produced IL-4 into their culture fluids, although MCP-1 was not produced by CSF-T cells. IL-4 production by CSF-T cells was markedly enhanced when they were stimulated with viral antigen in the presence of murine recombinant MCP-1 (rMCP-1). Furthermore, IL-4 was produced in naive splenic T cells cocultured with CSF-Mphi. These results indicate that the severity of HSM is influenced by MCP-1, which stimulates Th2 responses.
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
S. Ishida, A. Moriguchi, S. Sakane, K. Furukawa, H. Nakajima: "Herpes simplex encephalitis with expanded cerebral cortex lesions on T1-weighted MRI after clinical improvement"Clin Neurol. 42. 536-539 (2002)
S. Ishida、A. Moriguchi、S. Sakane、K. Furukawa、H. Nakajima:“临床改善后,T1 加权 MRI 上出现单纯疱疹性脑炎伴大脑皮层病变扩大”Clin Neurol。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
土居芳充, 古玉大介, 木村文治, 花房俊昭, 篠田恵一: "抗カルジオリピン抗体陽性を示す慢性炎症性脱髄性多発根ニューロパチーの臨床的特徴"Neuroimmunology. 11・1. 110 (2003)
土井义光、古玉大辅、木村文晴、花房敏明、筱田敬一:“抗心磷脂抗体阳性的慢性炎症性脱髓鞘性多发性神经根神经病的临床特征”11・1(2003)。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
Y. Doi, H. Nakajima, D. Furukawa, F. Kimura, T. Hanafusa, K. Shinoda: "Clinical manifestations of chronic inflammatory demyelinating polyneuropathy with anti-cardiolipin antibodies"Neuroimmunology. 11. 110 (2003)
Y. Doi、H. Nakajima、D. Furukawa、F. Kimura、T. Hanafusa、K. Shinoda:“抗心磷脂抗体慢性炎症性脱髓鞘性多发性神经病的临床表现”神经免疫学。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Nakajima, M.Kobayashi R.B.Pollard, F.Suzuki: "Monocyte chemoattractant protein-1 enhances HSV-induced encephalomyelitiss by stimulating Th2 responses"Journal of Leukocyte Biology. 70. 374-380 (2001)
H.Nakajima、M.Kobayashi R.B.Pollard、F.Suzuki:“单核细胞趋化蛋白-1 通过刺激 Th2 反应增强 HSV 诱导的脑脊髓炎”白细胞生物学杂志。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
石田志門, 森口暁仁, 坂根貞樹, 古川恵三, 中嶋秀人: "症状改善後に頭部MRI-T1強調画像にて高信号病域の拡大を認めた単純ヘルペス脳炎の1例"臨床神経学. 42・6. 536-539 (2002)
Shimon Ishida、Akihito Moriguchi、Sadaki Sakane、Keizo Furukawa、Hideto Nakajima:“症状改善后在头部 MRI-T1 加权图像上观察到高信号区域扩大的单纯疱疹性脑炎病例”《临床神经病学》42・6。 -539 (2002)
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 18 条
Establishment of treatment target for MS: Thyroid hormone receptor beta1 signaling is critically involved in the EAE pathogenesis
-
批准号:16K09704
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.0万
-
财政年份:2016
-
负责人:NAKAJIMA Hideto
-
依托单位:
Scientific Research of Michael Polanyi
-
批准号:21500974
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2009
-
负责人:NAKAJIMA Hideto
-
依托单位:
Intrathecal regulation of chemokine, oxidative stress, and inflammatory molecules on the pathogenesis of herpes simplex encephalitis
-
批准号:18590959
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.75万
-
财政年份:2006
-
负责人:NAKAJIMA Hideto
-
依托单位:
A Research on the Origin of the Scientific Instruments of Robert Hooke
-
批准号:15500657
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:2003
-
负责人:NAKAJIMA Hideto
-
依托单位:
国内基金
海外基金
芍药苷靶向α-烯醇化酶治疗实验性自身免疫性脑脊髓炎的机制研究
-
批准号:82371809
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:聂红
-
依托单位:
多发性硬化相关microRNA和靶基因鉴定及其对Th17和Treg细胞生成及分化的作用
-
批准号:81171120
-
项目类别:面上项目
-
资助金额:57.0万元
-
批准年份:2011
-
负责人:付锦
-
依托单位: